Bacterial Etiology of Adult Community-Acquired Pneumonia in Pakistan: A Systematic Review and Meta-Analysis
Article Sidebar
Main Article Content
Abstract
Background: Accurate knowledge of the epidemiology of community-acquired pneumonia (CAP) is essential for guiding appropriate antimicrobial therapy. This systematic review and meta-analysis aimed to identify and quantify the prevalence of common bacterial pathogens responsible for CAP in adult patients in Pakistan to improve empirical treatment strategies.
Methods: We systematically searched EMBASE, PubMed, Web of Science, and Google Scholar for studies published in English between January 1, 2000, and December 1, 2024. Studies were included if they reported bacterial etiology of radiologically confirmed CAP in adult patients in Pakistan. Quality assessment was performed using standardized criteria, and a random-effects model was used for meta-analysis. Seven studies met the inclusion criteria, comprising 1,793 CAP patients from three major cities: Karachi (n=4 studies), Lahore (n=1), and Rawalpindi (n=1).
Results: Meta-analysis revealed Streptococcus pneumoniae as the predominant pathogen (14%, 95% CI: 8-20%), followed by Pseudomonas aeruginosa (12%, 95% CI: 3-21%), Haemophilus influenzae (9%, 95% CI: 2-16%), and Staphylococcus aureus (8%, 95% CI: 2-13%). Significant heterogeneity was observed across studies (I² > 94% for all pathogens), attributable to variations in patient demographics (mean age range: 44.8-63.6 years), diagnostic methods (primarily sputum and blood cultures), and clinical settings (5 inpatient and 2 outpatient studies).
Conclusion: While S. pneumoniae emerged as the leading pathogen in Pakistani adults with CAP, the high heterogeneity and limited geographic representation suggest the need for more comprehensive research. Future studies should: 1) include diverse geographic areas, particularly rural settings, 2) employ standardized diagnostic methods, and 3) investigate pathogen-specific impacts on disease severity and outcomes to enhance CAP management strategies in Pakistan.
Downloads
Article Details
Copyright (c) 2025 Khowaja R, et al.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Chang DC, Anderson S, Wannemuehler K, Engelthaler DM, Erhart L, Sunenshine RH, et al. Testing for coccidioidomycosis among patients with community-acquired pneumonia. Emerg Infect Dis. 2008;14(7):1053. Available from: https://doi.org/10.3201/eid1407.070832
Brar NK, Niederman MS. Management of community-acquired pneumonia: a review and update. Ther Adv Respir Dis. 2011;5(1):61-78. Available from: https://doi.org/10.1177/1753465810381518
Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736-88. Available from: https://doi.org/10.1016/s0140-6736(18)32203-7
Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther. 1998;20:820-37. Available from: https://doi.org/10.1016/s0149-2918(98)80144-6
Luna CM, Famiglietti A, Absi R, Videla AJ, Nogueira FJ, Fuenzalida AD, et al. Community-acquired pneumonia—etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest. 2000;118:1344-54. Available from: https://doi.org/10.1378/chest.118.5.1344
World Health Organization. Global burden of disease (GBD). Geneva: World Health Organization; 2008. Available from: https://iris.who.int/bitstream/handle/10665/41864/0965546608_eng.pdf
Maruyama T, Fujisawa T, Ishida T, Ito A, Oyamada Y, Fujimoto K, et al. A therapeutic strategy for all pneumonia patients: a 3-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. Clin Infect Dis. 2019;68(7):1080-8. Available from: https://doi.org/10.1093/cid/ciy631
Self WH, Wunderink RG, Williams DJ, Zhu Y, Anderson EJ, Balk RA, et al. Staphylococcus aureus community-acquired pneumonia: prevalence, clinical characteristics, and outcomes. Rev Infect Dis. 2016;63(3):300-9. Available from: https://doi.org/10.1093/cid/ciw300
Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10:597–602. Available from: https://doi.org/10.1016/s1473-3099(10)70143-2
Jean SS, Hsueh PR. High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents. 2011;37:291–5. Available from: https://doi.org/10.1016/j.ijantimicag.2011.01.009
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W-65. Available from: https://doi.org/10.1016/j.jclinepi.2009.06.006
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101. Available from: https://pubmed.ncbi.nlm.nih.gov/7786990/
Etminan N, Chang HS, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, et al. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol. 2019;76(5):588–97. Available from: https://doi.org/10.1001/jamaneurol.2019.0006
Carugati M, Aliberti S, Sotgiu G, Blasi F, Gori A, Menendez R, et al. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study. Eur J Clin Microbiol Infect Dis. 2020;39:1513-25. Available from: https://doi.org/10.1007/s10096-020-03870-3
Iqbal N, Irfan M, Siddique F, Arshad V, Zubairi AB. Factors predicting in‐hospital mortality among patients admitted with community-acquired pneumonia at a tertiary care hospital Karachi, Pakistan. Clin Respir J. 2020;14(4):328-34. Available from: https://doi.org/10.1111/crj.13137
Irfan M, Hussain SF, Mapara K, Memon S, Mogri M, Bana M, et al. Community-acquired pneumonia: risk factors associated with mortality in tertiary care hospitalized patients. J Pak Med Assoc. 2009;59(7):448. Available from: https://pubmed.ncbi.nlm.nih.gov/19579732/
Khawaja A, Zubairi AB, Durrani FK, Zafar A. Etiology and outcome of severe community-acquired pneumonia in immunocompetent adults. BMC Infect Dis. 2013;13:1-6. Available from: https://doi.org/10.1186/1471-2334-13-94
Perveen I, Sehar S, Naz I, Ahmed S. Prevalence and antibiotic sensitivity profiles of bacteria causing community-acquired pneumonia in Rawalpindi, Pakistan. Int J Infect Dis. 2018;73:160. Available from: https://www.ijidonline.com/article/S1201-9712(18)33860-8/fulltext
Rehman S, Rehman K, Akash MS. A prospective study of inpatients to determine microbial etiology and therapeutic outcome of antibiotics for community-acquired pneumonia in Pakistan. Bioimpacts. 2013;3(2):91. Available from: https://doi.org/10.5681/bi.2013.023
Zubairi AB, Zafar A, Salahuddin N, Haque AS, Waheed S, Khan J. Atypical pathogens causing community-acquired pneumonia in adults. JPMA. J Pak Med Assoc. 2012;62(7):653. Available from: https://pubmed.ncbi.nlm.nih.gov/23866508/
Peto L, Nadjm B, Horby P, Ngan TT, van Doorn R, Kinh NV, et al. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg. 2014;108(6):326-37. Available from: https://doi.org/10.1093/trstmh/tru058
Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J Suppl. 2002;36:20s–27. Available from: https://doi.org/10.1183/09031936.02.00702002
Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med. 1999;160(2):397-405. Available from: https://doi.org/10.1164/ajrccm.160.2.9808045
Nascimento-Carvalho AC, Ruuskanen O, Nascimento-Carvalho CM. Comparison of the frequency of bacterial and viral infections among children with community-acquired pneumonia hospitalized across distinct severity categories: a prospective cross-sectional study. BMC Pediatr. 2016 Dec;16:1-0. Available from: https://doi.org/10.1186/s12887-016-0645-3
Kruckow KL, Zhao K, Bowdish DM, Orihuela CJ. Acute organ injury and long-term sequelae of severe pneumococcal infections. Pneumonia. 2023;15(1):5. Available from: https://doi.org/10.1186/s41479-023-00110-y
Rudkjøbing VB, Thomsen TR, Xu Y, Melton-Kreft R, Ahmed A, Eickhardt S, et al. Comparing culture and molecular methods for the identification of microorganisms involved in necrotizing soft tissue infections. BMC Infect Dis. 2016;16:1-3. Available from: https://doi.org/10.1186/s12879-016-1976-2
Anderson R, Feldman C. The global burden of community-acquired pneumonia in adults, encompassing invasive pneumococcal disease and the prevalence of its associated cardiovascular events, with a focus on pneumolysin and macrolide antibiotics in pathogenesis and therapy. Int J Mol Sci. 2023;24(13):11038. Available from: https://doi.org/10.3390/ijms241311038
Elias C, Nunes MC, Saadatian-Elahi M. Epidemiology of community-acquired pneumonia caused by Streptococcus pneumoniae in older adults: a narrative review. Curr Opin Infect Dis. 2024;37(2):144-53. Available from: https://doi.org/10.1097/qco.0000000000001005